Historical Company Announcements

Investor Centre

Unrivalled Economic Potential.

Here you will find the historical company information, including previous announcements, financial reports, and other important updates.
IHL_HeroVis_4@2x;

Historic Company Announcements

DateDescriptionView
Aug 30, 2023Annual Report and Appendix 4E
Aug 30, 2023Clarification to Top 20 in Annual Report
Aug 24, 2023Incannex to Prepare IND Application for Psi-GAD
Aug 22, 2023US FDA Completes Review of IHL-42x IND Application
Aug 10, 2023IHL Provides Shareholder Information Events for Redomiciling
Aug 9, 2023Change of Director’s Interest Notice
Aug 8, 2023Psychedelic Treatment Registrations start at Clarion Clinics
Aug 1, 2023Incannex Provides Access to Advisory Firm for Redomicile
Jul 28, 2023Quarterly Activities and Appendix 4C Cash Flow Report
Jul 26, 2023IHL Completes Pre-IND Meeting with US FDA on IHL-675A
Showing 21 to 30 of 1128 announcements
1 2 3 4 5 … 113

Historical results and presentations

Incannex intention to redomicile to US
OSA Announcement
Psychennex Company Update May 2023
The latest news

Clinical trials

See all news & media

Investor Inquiries

For investor related enquiries please contact:

Brad Dilkes
Email: investors@incannex.com.au

Media Inquiries

For media related enquiries please contact:

Joel Latham
Email: admin@incannex.com.au

Subscribe and stay connected

Stay up to date with Incannex’s leading research and development programs, multiple secondary assets, investor relations and biotechnology advancements.

"*" indicates required fields